Client Background
Our client is a German medtech startup developing next-generation remote patient monitoring solutions. Their vision is to create accessible, clinically-validated wearable devices for continuous vital sign tracking in both hospital and remote care settings.
Their flagship product is a compact, medical-grade wearable monitor that tracks heart rate, SpO2, and body temperature with clinical accuracy. The target market includes ICU departments, remote monitoring centers, and telehealth providers across Europe and North America.
Facing strong demand and tight deadlines, the client needed a manufacturing partner with expertise in high-volume production and medical-grade hardware. However, as a team composed mainly of software engineers and clinicians, they lacked in-house experience in medical PCB design, manufacturing infrastructure, and regulatory pathways—posing a critical challenge despite their advanced algorithms and software.
Client’s Challenges
Client’s Challenges
The German startup faced four main problems that were connected and threatened to delay their product launch:
1. Extreme Space Constraints and Component Density
The wearable needed to be small and comfortable enough for patients to wear all the time—its size was only about 55mm × 40mm × 12mm. Inside, it had to hold a complete multi-sensor system. This included optical sensors for measuring pulse and blood oxygen (similar to MAX30102 chips), parts to measure body temperature, a powerful microcontroller (the device’s brain), a Bluetooth 5.2 module for wireless connection, a circuit to manage the rechargeable battery, and backup power parts. Arranging all these components into such a tiny space, without causing electronic interference or overheating, required advanced circuit board design skills that the startup’s team did not have. Common layouts used in fitness trackers were not good enough—this was a medical device that needed clinical-level accuracy.
2. They Were Under Extreme Time Pressure
The startup was competing with established medical device companies and faced investor-imposed deadlines for prototype completion and regulatory certification. They needed to progress from hardware design to regulatory-ready prototypes within 6 months—a timeline that typically requires seamless collaboration between design, manufacturing, and regulatory expertise. Attempting to manage this internally, while simultaneously developing software and clinical validation protocols, was logistically impossible.
3. Meeting Medical Rules and Regulations Was Complex and Unfamiliar
Medical wearables are not like regular consumer electronics. To sell their device, the startup had to get it approved by health authorities in both the US (through a process called FDA 510(k) clearance) and Europe (by obtaining a CE mark under the EU Medical Device Regulation, MDR 2017/745). This meant they had to do extensive testing and paperwork, including:
- Biocompatibility testing (ISO 10993-1) to make sure the materials were safe for skin contact.
- Electromagnetic compatibility checks (IEC 60601-1-2) to ensure the device didn’t interfere with other medical equipment.
- Performance validation and clinical evaluation reports to prove the device worked accurately and reliably.
Furthermore, the circuit board (PCB) had to be built to the highest (Class 3) quality standards. Every part and step had to be carefully documented so it could be traced and checked by auditors. The startup had no experience with this complex regulatory process and couldn’t afford to have their design fail and need rework during certification.
4. They Needed to Mass-Produce the Device Reliably
Beyond prototypes, the startup projected volume ramp to 50,000 units annually within 18 months. This required a manufacturing partner with proven experience in medical device assembly, advanced test capabilities, and quality management systems certified to ISO 13485. Small design errors would become catastrophic at volume—poor PCB reliability, thermal issues, or intermittent sensor failures affecting thousands of units in clinical settings. The client needed a partner who could guarantee consistency from pilot production through high-volume manufacturing.
Our Solution
IWDF Solutions approached this project with a comprehensive, integrated strategy combining advanced PCB design, manufacturing expertise, and regulatory support.
Phase 1: Strategic Design Optimization (Weeks 1-4)
Our engineering team began by conducting a detailed requirements analysis with the client’s hardware architects. We performed a competitive teardown analysis of existing medical wearables and conducted thermal simulation studies to understand the device’s power dissipation profile. Based on these insights, we designed a proprietary 6-layer PCB stack-up optimized for signal integrity and miniaturization:
- Layer 1 (Top): High-density component placement optimized for optical sensors and Bluetooth antenna integration
- Layer 2: Mixed signal layer with carefully routed analog sensor conditioning circuits
- Layer 3: Ground plane with thermal vias connecting to thermal management layer
- Layer 4: Primary power distribution layer with careful voltage domain separation (3.3V core, 1.8V analog front-end)
- Layer 5: Secondary signal layer for low-speed digital connections and battery management
- Layer 6 (Bottom): Return path plane with integrated shielding traces for EMI suppression
The final PCB measured just 54mm × 38mm × 1.6mm total thickness—compressed from the initially proposed 8-layer design. This aggressive miniaturization was achieved through:
- Ultra-tight 4mil trace/space routing for non-critical signals
- Buried via technology for signal layer separation without increasing board area
- High-density BGA component placement for the main MCU (0.5mm pitch)
- Integrated antenna design eliminating external antenna components
- Strategic use of 0.4mm pitch capacitor arrays for power distribution
Phase 2: Sensor Integration and Signal Conditioning (Weeks 5-8)
The optical pulse oximetry system required a precise analog front-end design. We implemented a custom signal conditioning circuit around the optical sensor module that:
- Reduced noise floor to <0.2% THD through careful PCB layout and analog filtering
- Achieved temperature compensation across -10°C to +50°C operating range
- Integrated three independent analog channels (red LED, IR LED, temperature) with <0.1% cross-talk
- Designed low-impedance power distribution specific to LED drive requirements (peak current 100mA)
For Bluetooth connectivity, we implemented a controlled impedance transmission line for the antenna connection (50Ω ±10%) and segregated RF traces from analog sensing circuitry using strategic ground plane segmentation and shielding vias.
Phase 3: Manufacturability and Testability Design (Weeks 9-12)
We designed the board for our high-volume manufacturing capabilities:
- Implemented Design for Manufacturing (DFM) principles, including a selective solder mask for BGA rework access
- Added comprehensive test points for automated optical inspection (AOI) and in-circuit testing (ICT)
- Designed assembly panelization for optimized throughput (12 units per panel)
- Specified Controlled Impedance tracing documentation with a 10% tolerance band for consistent RF performance
- Embedded test pads for functional verification at both bare board and assembled PCB stages
Phase 4: Design for Regulatory Compliance (Weeks 13-16)
We collaborated closely with a certified notified body to ensure design documentation met CE marking requirements. This included:
- Complete design history file (DHF) with all revision controls and design justifications
- Risk analysis documentation linking PCB design decisions to hazard mitigation
- EMC design verification, including conducted and radiated emissions modeling
- Biocompatibility material certifications for all PCB surface finishes and adhesives
- Traceability matrix connecting design specifications to manufacturing test procedures
Results
1. Time-to-Market Acceleration: 32% Reduction in Development Cycle
By leveraging our integrated design and manufacturing expertise, we compressed the hardware development timeline from the projected 7 months to 4.8 months. This acceleration came from:
- Eliminating design iteration cycles through upfront DFM analysis (1 revision vs. projected 3-4 rounds)
- Parallel regulatory documentation during design phase rather than post-design
- Immediate manufacturing feedback during design prototyping
The device moved from concept to FDA/CE-ready prototype 8 weeks ahead of the startup’s internal projections, enabling them to meet investor milestones and secure critical funding for clinical trials.
2. Manufacturing Cost Reduction: 28% Lower Unit Cost at Volume
Our design optimization and manufacturing expertise delivered significant economics:
- The miniaturized 6-layer design vs. alternative 8-layer approaches saved $8.50 per unit in material and labor
- Optimized assembly process reduced labor-intensive hand-soldering requirements by 40%
- Integrated antenna eliminated $12 external connector/antenna module cost
- High-yield manufacturing process (97.8% first-pass yield) reduced scrap and rework overhead
At 50,000 unit annual volume, these per-unit savings translated to $1.26 million in annual production cost reduction—directly improving the client’s gross margins and competitive positioning.
3. Product Quality and Reliability: 97.8% Manufacturing Yield
Our rigorous design and manufacturing approach achieved exceptional reliability metrics:
- Zero field failures related to PCB defects across a 500-unit clinical trial cohort
- 99.2% sensor accuracy validation (heart rate ±1bpm, SpO2 ±2%, temperature ±0.3°C) across full operating range
- 18-month accelerated life testing showing <0.5% failure rate—well exceeding Class 3 medical device requirements
- Thermal management maintained sensor accuracy within ±0.1°C across the full operating range despite ambient temperature swings
4. Accelerated Regulatory Pathway: Certification Timeline Compressed by 40%
By embedding regulatory design principles into the PCB architecture from day one, we eliminated post-design compliance rework:
- FDA 510(k) submission prepared in parallel with manufacturing pilot, reducing total approval timeline by 12 weeks
- CE marking obtained 8 weeks ahead of the projected timeline through integrated notified body collaboration
- Zero design change requests from regulatory reviewers—our design documentation was complete and defensible
The client received CE marking clearance in their target markets 5 months post-prototype delivery.
Client Feedback
“Working with your team made a real difference for us. You understood the regulatory and technical challenges from day one and helped us turn a concept into a working prototype in record time. The PCB was stable, clean, and passed all our internal tests on the first run. We’ve already integrated it into pilot units for hospital trials.”
— Johannes S., CTO, Munich, Germany
Have a similar project in mind? Let’s make it happen — talk to our engineers today.
